Опухоли головы и шеи. 2012; : 13-17
МАКУЛОПАТИЯ ПОСЛЕ ТРАНСПУПИЛЛЯРНОЙ ТЕРМОТЕРАПИИ МЕЛАНОМ ХОРИОИДЕИ
https://doi.org/10.17650/2222-1468-2012-0-2-13-17Аннотация
У 23 больных изучены изменения макулярной зоны, возникающие после транспупиллярной термотерапии меланом хориоидеи экстрафовеолярной локализации. Выделены факторы риска развития этого осложнения: близкое расположение края опухоли до фовеолы (1−4,5 мм), темпоральная локализация меланомы, наличие сопутствующих заболеваний глазного дна (возрастная макулодистрофия, миопия высокой степени).
Список литературы
1. Линник Л.Ф., Яровой А.А. и др. Сравнительная оценка методов брахитерапии и диодлазерной транспупиллярной термотерапии при лечении меланом хориоидеи малых размеров. Офтальмохирургия 2004;2:64−70.
2. Journée-de Korver J.G., Oosterhuis J.A., Vrensen G.F. Light and electron microscopic findings on experimental melanomas after hyperthermia at 50 °C. Melanoma Res 1995; 5:393−402.
3. Aaberg T.M., Bergstrom C.S., Hickner Z.J., Lynn M.J. Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma. Br J Ophthalmol 2008; 92(6):741−4.
4. Shields C.L., Shields J.A., Perez N. et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology 2002;109:225.
5. Kiratli H., Bilgiç S. Choriovitreal neovascularization following transpupillary thermotherapy for choroidal melanoma. Eye 2003;17:437−9.
6. Бровкина А.Ф., Панова И.Е. Осложнения транспупиллярной термотерапии меланом хориоидеи, возможности их профилактики. Вестник офтальмологии 2010;2:18−21.
7. Archer D.B., Amaoka W.M.K., Gardner T.A. Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations. Eye 1991;5:239−51.
8. Shields C.L., Shields J.A., Cater J. et al. Transpupillary thermotherapy for choroidal melanoma. Tumor control and visual results in 100 consecutive cases. Ophthalmology 1998;105:581−90.
9. Connolly B.P., Regillo C.D., Eagle R.C. et al. The hystopathological effects of transpupillary thermotherapy in human eyes. Ophthalmology 2003;110:415−20.
10. Finger P.T., Chin K.J., Yu G.P. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Opthalmol 2010; 149(4):608−15.
11. Ginderdeuren R. van Limbergan E. van Spileers W. 18 Years’ experience with high dose rate stroncium-90 brachytherapy of smal to medium sozed posterior uveal melanoma. Br J Ophthalmol 2005; 89(10):1306−10.
12. Midena E., de Belvis V., Zaltron S. et al. Choroidal vascular patterns after transpupillary thermotherapy of choroidal melanoma [abstract]. Invest Ophthalmol Vis Sci 2001;42:444 (abstract 2394).
Head and Neck Tumors (HNT). 2012; : 13-17
MACULOPATHY AFTER TRANSPUPILLARY THERMOTHERAPY FOR CHOROIDAL MELANOMAS
https://doi.org/10.17650/2222-1468-2012-0-2-13-17Abstract
Macular area changes arising after transpupillary thermotherapy for extrafoveal choroidal melanomas were studied in 23 patients. Risk factors for this complication were identified; these were the tumor margin being close (1−4.5 mm) to the foveola; temporal localization of melanoma; eyeground comorbidity (age-related macular degeneration, high-grade myopathy).
References
1. Linnik L.F., Yarovoi A.A. i dr. Sravnitel'naya otsenka metodov brakhiterapii i diodlazernoi transpupillyarnoi termoterapii pri lechenii melanom khorioidei malykh razmerov. Oftal'mokhirurgiya 2004;2:64−70.
2. Journée-de Korver J.G., Oosterhuis J.A., Vrensen G.F. Light and electron microscopic findings on experimental melanomas after hyperthermia at 50 °C. Melanoma Res 1995; 5:393−402.
3. Aaberg T.M., Bergstrom C.S., Hickner Z.J., Lynn M.J. Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma. Br J Ophthalmol 2008; 92(6):741−4.
4. Shields C.L., Shields J.A., Perez N. et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology 2002;109:225.
5. Kiratli H., Bilgiç S. Choriovitreal neovascularization following transpupillary thermotherapy for choroidal melanoma. Eye 2003;17:437−9.
6. Brovkina A.F., Panova I.E. Oslozhneniya transpupillyarnoi termoterapii melanom khorioidei, vozmozhnosti ikh profilaktiki. Vestnik oftal'mologii 2010;2:18−21.
7. Archer D.B., Amaoka W.M.K., Gardner T.A. Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations. Eye 1991;5:239−51.
8. Shields C.L., Shields J.A., Cater J. et al. Transpupillary thermotherapy for choroidal melanoma. Tumor control and visual results in 100 consecutive cases. Ophthalmology 1998;105:581−90.
9. Connolly B.P., Regillo C.D., Eagle R.C. et al. The hystopathological effects of transpupillary thermotherapy in human eyes. Ophthalmology 2003;110:415−20.
10. Finger P.T., Chin K.J., Yu G.P. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma. Am J Opthalmol 2010; 149(4):608−15.
11. Ginderdeuren R. van Limbergan E. van Spileers W. 18 Years’ experience with high dose rate stroncium-90 brachytherapy of smal to medium sozed posterior uveal melanoma. Br J Ophthalmol 2005; 89(10):1306−10.
12. Midena E., de Belvis V., Zaltron S. et al. Choroidal vascular patterns after transpupillary thermotherapy of choroidal melanoma [abstract]. Invest Ophthalmol Vis Sci 2001;42:444 (abstract 2394).
